Frank Abele, CEO of MEDICLIN Aktiengesellschaft (MediClin), will leave the Company at the end of the year 2013 by his own request. After nearly fifteen years, first as CFO and then as CEO of MediClin, he will devote himself to new entrepreneurial tasks. The decision of Mr. Abele is regretted by the Supervisory Board but he accepted the wish of Mr. Abele not to extend his Management Board contract.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.92 EUR | +2.82% | +0.69% | +6.57% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.57% | 147M | |
-18.84% | 16.76B | |
+3.60% | 12.65B | |
+3.98% | 11.86B | |
+4.28% | 10.28B | |
+28.60% | 8.67B | |
-7.64% | 7.6B | |
+6.40% | 6.8B | |
+8.59% | 6.52B | |
+39.21% | 4.53B |
- Stock Market
- Equities
- MED Stock
- News MEDICLIN AG
- Mediclin Announces Frank Abele to Leave as CEO at the End of the Year 2013